Touton giant cells are a special type of large immune cell that a pathologist may see when examining tissue under the microscope. They form when several histiocytes (a type of immune cell) that have taken up fat fuse into a single large cell with multiple nuclei. Touton giant cells are a descriptive finding, not a diagnosis in themselves. They are reported as one feature within a tissue sample, and their meaning depends on the other findings and the final diagnosis.
This article explains what Touton giant cells are and why they may be mentioned in your pathology report.
Touton giant cells have a distinctive appearance that pathologists recognize easily. They form when fat-filled histiocytes fuse into a single large cell. The many nuclei inside the cell are arranged in a ring, or wreath, around a central core of pink (eosinophilic) cytoplasm. Outside this ring of nuclei, the cytoplasm looks pale and bubbly, or “foamy,” because it is filled with fat. This combination of a central pink zone, a ring of nuclei, and a foamy outer rim is what sets a Touton giant cell apart from other giant cells.
Touton giant cells are typically found in conditions in which fat accumulates within immune cells, sometimes called fatty or xanthogranulomatous processes. They are most often seen in benign (noncancerous) conditions but can also appear in rare tumors. Conditions in which Touton giant cells may be reported include:
Because Touton giant cells can appear in several different conditions, they are used as one clue among many rather than as proof of any single diagnosis.
Seeing Touton giant cells indicates that the tissue contains a fatty or xanthogranulomatous process, which helps narrow down the possible diagnoses. On their own, Touton giant cells do not indicate whether a condition is harmful. Most conditions that contain them are benign, but a few, such as Erdheim-Chester disease, are neoplasms. For this reason, the pathologist considers Touton giant cells together with the other microscopic features, the results of any special tests such as immunohistochemistry, and the clinical situation before reaching a final diagnosis. The meaning of this finding in your report depends on that overall diagnosis, which your doctor can explain.